Search Share Prices
AZN News - AstraZeneca cancer drug fast-tracked by the FDA
Anglo-Swedish drugs giant AstraZeneca PLC (LON:AZN) has been granted a priority review for a new drug’s use in a particularly aggressive and untreated form of lung cancer. Imfinzi, which is already ...
Shore Capital Reaffirms Buy Rating for AstraZeneca (LON:AZN)
AstraZeneca (LON:AZN)‘s stock had its “buy” rating reaffirmed by investment analysts at Shore Capital in a research note issued to investors on Friday, ThisIsMoney.Co.Uk reports. Other equities ...
AstraZeneca's near-£100bn valuation is a vindication for Pascal Soriot
Since the Frenchman took the helm in October 2012, the drug giant's share price has increased by over 160% The firm's success is a far cry from 2014, when it was battling a hostile takeover from US ...
Why the Astrazeneca share price (LON:AZN) could go higher
The rational investor can take advantage of this mispricing. Stockopedia’s Momentum Rank is a convenient way of summarising the momentum attributes of a stock - let’s use Astrazeneca (LON:AZN) as an ...
Demand For Immune-Oncology Treatments To Reach A Market Value Of USD 157,230.48 Million On The Back Of Rising Cases Of Cancer By 2027
Hoffmann-La Roche Ltd (swx:ROG), Merck & Company, Inc. MRK, +0.41%, AstraZeneca Plc. (lon:AZN), Novartis (swx:NOVN), Amgen Inc. AMGN, +1.08%, Pfizer Inc. PFE, +2.00%, Bristol-Myers Squibb Company BMY, ...